Benjamin Phillips
Overview
Explore the profile of Benjamin Phillips including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
798
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karp N, Sharpe A, Phillips B
Lab Anim
. 2024 Aug;
58(5):481-485.
PMID: 39102517
Pilots are small-scale initial experiments that are intended to guide the design of future, larger studies, with a view to increasing their effectiveness. In this statistical primer we highlight five...
2.
Stagge J, Torbenson M, Sung K, Phillips B, Kingston D
Nat Water
. 2024 Apr;
1(12):1016-1026.
PMID: 38666263
A large proportion of western North America experiences regular water stress, compounded by high seasonal and interannual variability. In the Intermountain West region, the El Niño/Southern Oscillation (ENSO) is a...
3.
Grazini U, Markovets A, Ireland L, ONeill D, Phillips B, Xu M, et al.
Clin Cancer Res
. 2024 Apr;
30(18):4143-4154.
PMID: 38630555
Purpose: Osimertinib is an EGFR tyrosine kinase inhibitor indicated for the treatment of EGFR-mutated (EGFRm)-driven lung adenocarcinomas. Osimertinib significantly improves progression-free survival in first-line-treated patients with EGFRm advanced non-small cell...
4.
Phillips B, Haschler T, Karp N
PLoS Biol
. 2024 Apr;
22(4):e3002578.
PMID: 38607970
No abstract available.
5.
Hervig M, Zuhlsdorff K, Olesen S, Phillips B, Bozic T, Dalley J, et al.
Psychopharmacology (Berl)
. 2024 Apr;
241(8):1631-1644.
PMID: 38594515
Rationale: Cognitive flexibility, the ability to adapt behaviour in response to a changing environment, is disrupted in several neuropsychiatric disorders, including obsessive-compulsive disorder and major depressive disorder. Evidence suggests that...
6.
Hardaker E, Sanseviero E, Karmokar A, Taylor D, Milo M, Michaloglou C, et al.
Nat Commun
. 2024 Feb;
15(1):1700.
PMID: 38402224
The Ataxia telangiectasia and Rad3-related (ATR) inhibitor ceralasertib in combination with the PD-L1 antibody durvalumab demonstrated encouraging clinical benefit in melanoma and lung cancer patients who progressed on immunotherapy. Here...
7.
Zhang T, Phillips B, Karp N, Wang J, Novick S
J Biopharm Stat
. 2023 Sep;
:1-11.
PMID: 37724802
Following good statistical practice, study investigators allocate animals into two or more treatment groups using a randomization routine to eliminate selection bias and balance known and unknown confounding factors. For...
8.
9.
Phillips B, Haschler T, Karp N
PLoS Biol
. 2023 Jun;
21(6):e3002129.
PMID: 37289836
In recent years, there has been a strong drive to improve the inclusion of animals of both sexes in the design of in vivo research studies, driven by a need...
10.
Harte E, Kumarasamysarma S, Phillips B, Mackay O, Rashid Z, Malikova N, et al.
Antibiotics (Basel)
. 2023 Apr;
12(4).
PMID: 37107071
The development of secondary bacterial infections in COVID-19 patients has been associated with increased mortality and worse clinical outcomes. Consequently, many patients have received empirical antibiotic therapies with the potential...